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Collagen type XVIII (C18) belongs to a novel class of nonfibrillar
collagens forming, together with collagen type XV, the multiplexin
(multiple triple-helix domains with interruptions) subgroup within
the collagen superfamily. These proteins are characterized by a large
globular N-terminal domain, a highly interrupted triple-helical region
and a globular C-terminus with four conserved cysteines (Muragaki
et al, 1994; Oh et al, 1994a; Rehn and Pihlajaniemi, 1994). 
C18 is expressed in highly vascularized organs such as liver,
lung, kidney and placenta (Oh et al, 1994b; Muragaki et al, 1995;
Rehn and Pihlajaniemi, 1995; Musso et al, 1998; Saarela et al,
1998). Immunohistochemistry suggested a structural role for C18
in the formation of specialized epithelial and endothelial basement
membranes (Muragaki et al, 1995; Musso et al, 1998; Saarela et al,
1998). A 22 kDa C-terminal proteolytic fragment of C18, endo-
statin, has been identified as a potent inhibitor of angiogenesis and
tumor growth in mice (Boehm et al, (1997); O’Reilly et al, 1997).
Furthermore, endostatin inhibits migration and proliferation and
induces apoptosis of endothelial cells in vitro (O’Reilly et al,
1997; Dhanabal et al, 1999a, 1999b; Taddei et al, 1999). 
Expression of C18 RNA in normal liver, which was shown to 
be the major C18-producing organ both in man and rodents
(Muragaki et al, 1994, 1995; Oh et al, 1994b; Rehn and
Pihlajaniemi, 1995; Musso et al, 1998) is nearly confined to
hepatocytes and bile duct epithelia and is up-regulated in these
cells in cirrhosis and hepatocellular carcinoma. The high expres-
sion by neoplastic hepatocytes in vivo supports a unique role of
this collagen not only in the formation of the sinusoidal basement
membrane but also in the regulation of angiogenesis and
neoplastic transformation (Schuppan et al, 1998). 
Here we extended these studies analysing the origin and distrib-
ution of C18 in colonic adenocarcinoma metastases as the most
frequently occurring secondary liver tumours, compared to normal
colonic mucosa and to primary colon cancer. In addition, we
studied primary ovarian carcinomas which are difficult to distin-
guish from colon carcinoma metastases to the ovaries. 
MATERIALS AND METHODS 
Tissues 
Tissue samples were obtained from patients undergoing resection
for colorectal tumours (n = 16) or partial liver resection for solitary
colorectal liver metastases (n = 5). Tissue samples were snap-
frozen in liquid nitrogen immediately after removal and submitted
for histopathologic diagnosis. The patient data and the histopatho-
logic characteristics are listed in Table 1. As controls, we used
colonic tissues with regular histology (at a distance of >10 cm
from the focal lesions, n = 6) as well as resectates of ovarian carci-
nomas (n = 10) and one normal ovary. 
Tissue sectioning and fixation 
Frozen sections (7 µ m) were collected onto 3-aminopropyl trietho-
xysilane-coated slides, dried briefly on a hot plate at 80˚C, and fixed
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in 4% paraformaldehyde/phosphate-buffered saline (PBS), pH 7.4,
for 20 minutes. After 2 washes in PBS, dehydration in graded
ethanols, and short air drying, sections were stored at –80˚C. 
Immunohistology 
The immunohistochemical detection of endostatin was performed
with polyclonal rabbit antibodies specific for murine endostatin (kind
gift of Dr U Eberspaecher and Dr A Menrad, Schering-AG, Berlin,
Germany) with cross-reactivity to human endostatin. The alkaline
phosphatase anti-alkaline phosphatase (APAAP) method was used
for immunohistology, using affinity-purified mouse anti-rabbit
immunoglobulin (Dianova, Hamburg, Germany), affinity-purified
rabbit anti-mouse immunoglobulin (Dako, Glostrup, Denmark), and
the APAAP complex (1:20 dilution, Dako). Alkaline phosphatase
was developed with new fuchsin. 
Preparation and labelling of probes 
The probes were generated by oligo(dT)-primed reverse transcrip-
tion of human liver RNA followed by amplification with 
oligo-deoxyribonucleotide primers corresponding to nucleotides
1483–1501 (CGA CCC ACA AGC CCA CCC G) and
2083–2062 (TCT CCG GCC ATC TGC ATC CAG G) for the 
endostatin-encoding region, and to nucleotides 168–190 (GGG
ACC TGT GGT CTA CGT GTC GG) and 809–787 (TCG CCT
TTC TGT CCT GCA TCA CC) for the collagenous domain of
C18 (Oh et al, 1994b). The amplicons were cloned into the EcoRV
site of pZErO-1 (Invitrogen, Leek, Netherlands) and further char-
acterized by restriction digests and sequence analysis. After appro-
priate linearization of the plasmids, T7 or SP6 RNA-polymerase
(Gibco-BRL, Eggenstein, Germany), respectively, were employed
to obtain run-off transcripts of either the anti-sense (complemen-
tary to cellular RNA), or sense (control) strands. Transcription and
labelling of RNA probes were performed as described using [35S]-
uridine-5′ -(α -thio)-triphosphate (1250 Ci mmole–1, New England
Nuclear, Dreieich, Germany) (Milani et al, 1990; Herbst et al,
1997). The specific activity routinely obtained was 1.2–1.4 × 109
cpm µ g–1. 
In situ hybridization 
Pre-hybridization, hybridization, washing procedures including
removal of non-specifically bound probe by ribonuclease A diges-
tion and autoradiography of slides were as described before
(Milani et al, 1990; Herbst et al, 1997). Controls included
hybridization with C18 sense probes as well as with a procollagen
α 1(I) probe (Milani et al, 1990). 
Table 1 Summary of clinical information and histopathological diagnoses 
Case Age Sex Diagnosis Histology 
1 84y M sigmoid carcinoma adenocarcinoma G2, pT4pN1 
2 75y M rectal carcinoma adenocarcinoma G2 
3 64y M colon asc. carcinoma adenocarcinoma G2, pT3pN1 
4 62y M rectal carcinoma adenocarcinoma G2, pT2pN2 
5 45y F sigmoid carcinoma adenocarcinoma G3, pT2pN2 
6 51y M rectal carcinoma adenocarcinoma G3, pT1pN0 
7 75y M rectal carcinoma adenocarcinoma G2, pT3pN0 
8 75y M rectal carcinoma mucinous adenocarcinoma G3, pT3pN0 
9 68y M rectal carcinoma adenocarcinoma G3, pT3pN2 
10 57y M rectal carcinoma adenocarcinoma G2, pT3pN1 
11 75y M rectal carcinoma adenocarcinoma G3, pT3pN0 
12 82y M rectal carcinoma adenocarcinoma G2, pT3pN0 
13 78y F rectal carcinoma adenocarcinoma G2, pT2pN0 
14 52y F rectal carcinoma adenocarcinoma G2, pT3pN1 
15 65y F rectal carcinoma adenocarcinoma G2, pT2pN0 
16 61y F sigmoid carcinoma adenocarcinoma G2, pT4pN0 
17 84y M sigmoid carcinoma normal histology distant to lesion 
18 (3) 64y M colon asc. carcinoma normal histology distant to lesion 
19 79y F colon carcinoma normal histology distant to lesion 
20 66y M colon carcinoma normal histology distant to lesion 
21 68y M colon carcinoma normal histology distant to lesion 
22 (16) 61y F sigmoid carcinoma normal histology distant to lesion 
23 70y F colon ca. metastasis adenocarcinoma G3, pM1HEP 
24 63y M rectal ca. metastasis adenocarcinoma G2, pM1HEP 
25 (21) 68y M colon ca. metastasis adenocarcinoma G3, pM1HEP 
26 (16) 61y F sigmoid ca. metastasis mucinous adenocarcinoma G3, pM1HEP 
27 34y M colon ca. metastasis adenocarcinoma G3, pM1HEP 
28 76y F ovarian carcinoma serous cystadenocarcinoma G3 
29 63y F ovarian carcinoma serous cystadenocarcinoma G3 
30 86y F ovarian carcinoma serous cystadenocarcinoma G2 
31 64y F ovarian carcinoma adenocarcinoma, transitional type G3 
32 38y F ovarian carcinoma endometrioid adenocarcinoma G3 
33 60y F ovarian carcinoma endometrioid adenocarcinoma G2 
34 54y F ovarian carcinoma adenocarcinoma NOS G3 
35 76y F ovarian carcinoma serous cystadenocarcinoma G3 
36 41y F ovarian carcinoma serous cystadenocarcinoma G2 
37 49y F ovarian carcinoma papillary serous cystadenoma, borderline type 
38 63y F ovary normal histology 
M, male; F, female. Parentheses: number of tissue samples of the same patient. 1542 U Guenther et al
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Immunohistology combined with in situ hybridization 
Sections were stained with monoclonal antibodies specific for
cytokeratin (clone KL-1, Dako), vimentin (clone V9, Dako),
smooth muscle α -actin (clone 1A4, Sigma Chemical Co, St Louis,
MO), and the endothelial cell marker CD31 (clone JC70A, Dako)
using the immunoalkaline phosphatase (APAAP) method as
described above (Herbst et al, 1997). 
RESULTS 
Normal colon 
Some C18 RNA-expressing cells were found within the lamina
muscularis propria, particularly in interspersing stromal tissue.
Only very few positive cells were seen in the lamina propria.
Epithelial cells did not display C18 RNA at detectable levels
(Figure 1A). 
Colorectal carcinomas and colorectal liver metastases 
A highly increased C18 RNA-expression was observed in peri-
tumourous stromal cells, both of primary tumours and metastases.
The phenotype of these C18-positive cells was consistent with
stromal fibroblasts or endothelial cells of small vessels and capil-
laries. C18 RNA was only marginally detectable in the carcinoma
cells. Only a few tumour cells in 5 of 16 cases of colorectal carci-
nomas and 2 of 5 cases of colorectal liver metastases displayed a
weak signal slightly above the background (Figure 1B–D). In
colorectal liver metastases the C18 RNA-expression in the adja-
cent liver tissue showed a homogeneous labelling of all hepato-
cytes as previously described (Schuppan et al, 1998). In situ
hybridizations performed with both of the C18-specific RNA-
probes, encoding either the endostatin-domain or part of the
collagenous region, revealed an identical expression pattern. 
By combined immunohistochemical staining and in situ hybridiza-
tion the C18 RNA-expressing cells in the tumour stroma were identi-
fied as vimentin-positive mesenchymal cells. Many of the C18
RNA-positive cells also expressed smooth muscle α -actin, a marker
of a myofibroblastic differentiation, or the endothelial CD31 antigen
(Figure 2A), but cells were consistently negative for cytokeratin
(Figure 2B). 
By immunostaining, the C18/endostatin protein was found
within the tumour stroma, with prominent labelling of endothelial
cells of small vessels and capillaries, well in agreement with the
results of in situ hybridization. Carcinoma cells did not display
endostain immunoreactivity, whereas the sinusoidal basement
membranes of neighbouring liver parenchyma showed a linear but
weaker deposition of C18/endostatin (Figure 2E, F). 
Ovarian carcinomas 
In contrast to colon carcinomas, ovarian carcinoma cells showed
highly elevated C18 RNA transcript levels in 8 of 10 cases. However,
as in colorectal carcinomas and colorectal liver metastases, C18
mRNA expression was high in the tumour stroma (Figure 1E, F). C18
transcripts were almost homogeneously distributed among the groups
of tumour cells without variation along morphologically distinct sites
such as the front of invasion vs. more central tumour regions. There
was no relationship of C18 transcript levels with cellular or nuclear
characteristics of the tumour cells. Double-labelling experiments
documented that the vast majority of the cytokeratin-positive
carcinoma cells were expressing C18 RNA (Figure 2C). In the 2 cases
that displayed a transitional or endometrioid-type morphology only a
weak signal for C18 RNA was detected over the carcinoma cells (not
shown). As in colon carcinomas, combined immunohistochemical
staining and in situ hybridization allowed identification of the C18
RNA-expressing cells in the tumour stroma as vimentin (α -actin)-
positive fibroblasts/myofibroblasts or anti-CD31-positive endothelial
cells (Figure 2D). 
In one case of normal ovary no C18 RNA transcripts were
detectable, whereas the neighbouring epithelial lining of the Fallopian
tube displayed a weak signal. In situ hybridizations with sense (non-
complementary control) probes revealed a weak, nonspecific back-
ground labelling (not shown). High procollagen α 1(I) transcript
levels were detectable over fibroblastic cells of all specimens as proof
for integrity of the examined tissue samples (not shown). 
DISCUSSION 
As a component of specialized basement membranes, C18 merits
particular attention, since its proteolysis by proteases such as
cathepsin L and elastase generates the potent angiogenesis
inhibitor endostatin (Wen et al, 1999; Felbor et al, 2000). Previous
quantitative and in situ hybridization studies revealed a prominent
expression of C18 mRNA and protein in epithelia of liver and to a
minor degree in kidney and lung (Oh et al, 1994b; Muragaki et al,
1995; Rehn and Pihlajaniemi, 1995; Musso et al, 1998; Schuppan
et al, 1998). However, the patterns of C18 RNA expression in
primary colonic adenocarcinoma and its metastases as the most
frequently occurring secondary liver tumours, compared to normal
colon as well as to often morphologically similar ovarian carci-
nomas is largely unknown. 
Expression patterns of C18 in the liver tissue adjacent to the
metastases displayed high transcript levels in hepatocytes, and
lower levels in epithelial cells of small bile ducts and in endothe-
lial cells as described previously (Schuppan et al, 1998). However,
epithelia of colon carcinoma did not express C18 mRNA, while
high C18 RNA transcript levels were present in the tumour stroma
of both primary neoplasms and liver metastases. Here, fibroblasts
and endothelial cells were identified as prominent sources of C18. 
In contrast, ovarian carcinomas showed a strong C18 RNA
expression in tumour cells in 8 out of 10 cases. Also, C18 expres-
sion was highly elevated in tumour endothelial cells and fibro-
blasts in these tumours. The finding of a high epithelial expression
of C18 in ovarian cancer is of practical interest, since ovarian
carcinoma may spread to the intestinal wall and may then be
present in biopsy materials. Vice versa, gastrointestinal carci-
nomas may spread to the ovary. However, on microscopic exami-
nation ovarian endometrioid and mucinous carcinomas are often
indistinguishable from colon colorectal carcinoma metastatic to or
infiltrating the ovary, even when using the tumour markers CEA
and CA125. Therefore, C18 may serve as a novel marker to distin-
guish carcinoma of intestinal (absent C18 expression) vs. ovarian
(high C18 expression) origin. 
Our study demonstrates that epithelial cells of different origin
differ widely in their ability to express C18. While the low C18
expression of normal colonic epithelium is largely maintained in its
neoplastic counterparts, and a high C18 expression is found both in
normal and neoplastic hepatocytes (Schuppan et al, 1998), C18 is
clearly up-regulated in the epithelium of ovarian carcinomas. The
finding of variable C18 expression in adenocarcinomas dependingCollagen XVIII in colon and ovarian cancers 1543
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on their site of origin argues against a pivotal function of C18 in
early neoplastic transformation, but does not exclude a role of C18
in progression of ovarian carcinoma. In all cases, however, induc-
tion of peritumoural C18 expression by stromal endothelial cells
and fibroblasts appears to be relevant for tumour progression and
metastatic behaviour. 
Whereas intact C18 may promote endothelial cell survival and
angiogenesis, its C-terminal proteolytic fragment, endostatin, has
been shown to be a potent inhibitor of angiogenesis (Boehm et al,
1997; O’Reilly et al, 1997). Cathepsin L, one of the proteases
implicated in proteolytic cleavage of endostatin from its precursor
C18, is widely expressed in colorectal carcinomas as well as in the
colorectal cancer cell line HT-29 (Sheahan et al, 1989; Chauhan 
et al, 1991; Shuja et al, 1991; De Stefanis et al, 1997). Thus,
epithelial tumours potentially modulate their growth by generating
the proteases liberating endostatin from C18. The balance between
C18 expression and cathepsin L, elastase or other proteases
possibly involved in C18 processing may, therefore, be central for
the regulation of angiogenesis and the dynamics of tumour growth.
Importantly, the local production of C18 by the tumour cells opens
h
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Figure 1 In situ hybridization with the [35S]-labelled antisense RNA-probe for the endostatin-domain of C18 in normal colon (case 17; A), colon carcinoma
(cases 4, 9; B, C), colorectal liver metastasis (case 24; D) and ovarian carcinoma (cases 32, 34; E, F). In normal colon some C18 RNA-expressing cells are
found within the lamina muscularis propria (A). In colorectal carcinomas and colorectal liver metastases a highly upregulated C18 RNA-expression is seen in
the tumour stroma. Labelled cells are morphologically consistent with fibroblasts and endothelial cells. Carcinoma cells do not express C18 RNA at detectable
levels (B–D). Homogenous labelling of all hepatocytes (h) is present within the parenchyma adjacent to the liver metastasis (D). Tumour cells of ovarian
carcinomas display strong and homogeneous C18 RNA-expression, as do fibroblasts and endothelial cells of the tumour stroma (E, F). Autoradiographic
exposure time 35 days. Original magnification × 170 (A), × 120 (B–F) 1544 U Guenther et al
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the opportunity to suppress tumour growth via local induction of
these proteases. Furthermore, C18 expression may be used to char-
acterize the primary site of ill-defined adenocarcinomas. 
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